Comparison of bleeding risk and hypofibrinogenemia-associated risk factors between tigecycline with cefoperazone/sulbactam therapy and other tigecycline-based combination therapies

por Zhang, Lei, Cai, Xinfeng, Peng, Fangchen, Tian, Shuangshuang, Wu, Xinjing, Li, Yun, Guo, Jinlin
Publicado 2023